| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A pooled analysis of CYP2D6 genotype in breast cancer prevention trials of low-dose tamoxifen
|
Johansson, Harriet
|
|
2016
|
159 |
1 |
p. 97-108
|
artikel
|
| 2 |
Assessment of dual-probe Her-2 fluorescent in situ hybridization in breast cancer by the 2013 ASCO/CAP guidelines produces more equivocal results than that by the 2007 ASCO/CAP guidelines
|
Qian, Xiao-Long
|
|
2016
|
159 |
1 |
p. 31-39
|
artikel
|
| 3 |
A Survey of BRCA1, BRCA2, and PALB2 mutations in women with breast cancer in Trinidad and Tobago
|
Donenberg, Talia
|
|
2016
|
159 |
1 |
p. 131-138
|
artikel
|
| 4 |
Author’s response to “letter to the editor: lower vitamin D status may explain racial disparities in all-cause mortality among younger commercially insured women with incident metastatic breast cancer”
|
Leopold, Christine
|
|
2016
|
159 |
1 |
p. 175
|
artikel
|
| 5 |
Bilateral mastectomy and the retreat from breast-conserving surgery
|
Moffat, Frederick L.
|
|
2016
|
159 |
1 |
p. 15-30
|
artikel
|
| 6 |
Clinical and biological significance of RAD51 expression in breast cancer: a key DNA damage response protein
|
Alshareeda, Alaa Tarig
|
|
2016
|
159 |
1 |
p. 41-53
|
artikel
|
| 7 |
Erratum to: Nottingham prognostic index plus (NPI+) predicts risk of distant metastases in primary breast cancer
|
Green, Andrew R.
|
|
2016
|
159 |
1 |
p. 199
|
artikel
|
| 8 |
Erratum to: Rates of BRCA1/2 mutation testing among young survivors of breast cancer
|
Kehl, Kenneth L.
|
|
2016
|
159 |
1 |
p. 201
|
artikel
|
| 9 |
Expression of cancer-associated fibroblast-related proteins differs between invasive lobular carcinoma and invasive ductal carcinoma
|
Park, Cheol Keun
|
|
2016
|
159 |
1 |
p. 55-69
|
artikel
|
| 10 |
Impact of body mass index (BMI) on the prognosis of high-risk early breast cancer (EBC) patients treated with adjuvant chemotherapy
|
Gennari, Alessandra
|
|
2016
|
159 |
1 |
p. 79-86
|
artikel
|
| 11 |
Impact of race, ethnicity, and BMI on achievement of pathologic complete response following neoadjuvant chemotherapy for breast cancer: a pooled analysis of four prospective Alliance clinical trials (A151426)
|
Warner, Erica T.
|
|
2016
|
159 |
1 |
p. 109-118
|
artikel
|
| 12 |
Lower vitamin D status may explain racial disparities in all-cause mortality among younger commercially insured women with incident metastatic breast cancer
|
Grant, William B.
|
|
2016
|
159 |
1 |
p. 173
|
artikel
|
| 13 |
Patterns of change over time and history of the inflammatory potential of diet and risk of breast cancer among postmenopausal women
|
Tabung, Fred K.
|
|
2016
|
159 |
1 |
p. 139-149
|
artikel
|
| 14 |
Phase II studies of two different schedules of dasatinib in bone metastasis predominant metastatic breast cancer: SWOG S0622
|
Schott, Anne F.
|
|
2016
|
159 |
1 |
p. 87-95
|
artikel
|
| 15 |
Race/ethnicity, genetic ancestry, and breast cancer-related lymphedema in the Pathways Study
|
Kwan, Marilyn L.
|
|
2016
|
159 |
1 |
p. 119-129
|
artikel
|
| 16 |
Retrospective analysis of molecular scores for the prediction of distant recurrence according to baseline risk factors
|
Sestak, Ivana
|
|
2016
|
159 |
1 |
p. 71-78
|
artikel
|
| 17 |
Standardized measures of lobular involution and subsequent breast cancer risk among women with benign breast disease: a nested case–control study
|
Figueroa, Jonine D.
|
|
2016
|
159 |
1 |
p. 163-172
|
artikel
|
| 18 |
Therapy modalities to reduce lymphoedema in female breast cancer patients: a systematic review and meta-analysis
|
Rogan, Slavko
|
|
2016
|
159 |
1 |
p. 1-14
|
artikel
|
| 19 |
Treatment of early-stage human epidermal growth factor 2-positive cancers among medicare enrollees: age and race strongly associated with non-use of trastuzumab
|
Vaz-Luis, Ines
|
|
2016
|
159 |
1 |
p. 151-162
|
artikel
|
| 20 |
UK Breast Cancer Research Symposium 2016: Submitted Abstracts
|
|
|
2016
|
159 |
1 |
p. 177-197
|
artikel
|
Tijdschrift beschrijving